Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
197 studies found for:    PML
Show Display Options
Rank Status Study
1 Enrolling by invitation Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
2 Terminated
Has Results
Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention: Drug: mefloquine
3 Completed Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome
Conditions: PML;   AIDS
Intervention:
4 Unknown  Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic
Conditions: Relapsed Acute Promyelocytic Leukemia;   Refractory Acute Promyelocytic Leukemia
Interventions: Drug: Arsenic trioxide;   Drug: Trisenox
5 Recruiting Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
6 Recruiting Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: Arsenic trioxide;   Drug: Idarubicin;   Drug: Cytarabine;   Drug: Tretinoin;   Drug: Mitoxantrone;   Drug: Mercaptopurine;   Drug: Methotrexate
7 Completed Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: Arsenic Trioxide;   Procedure: Autologous Transplantation;   Procedure: Allogenic Transplantation;   Drug: ATRA
8 Terminated Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
9 Completed Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)
Condition: Acute Promyelocytic Leukemia
Intervention: Drug: AIDA
10 Completed A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients
Conditions: HIV Infections;   Leukoencephalopathy, Progressive Multifocal
Interventions: Drug: Cidofovir;   Drug: Probenecid
11 Recruiting Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk
Condition: Multiple Sclerosis
Intervention:
12 Completed Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients
Conditions: HIV Infections;   Leukoencephalopathy, Progressive Multifocal
Interventions: Drug: Filgrastim;   Drug: Cytarabine;   Drug: Zidovudine;   Drug: Zalcitabine;   Drug: Didanosine
13 Completed A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
Conditions: HIV Infections;   Leukoencephalopathy, Progressive Multifocal
Interventions: Drug: Interferon alfa-2b;   Drug: Zidovudine
14 Recruiting Proteasome Inhibition in Acute Promyelocytic Leukemia
Condition: Relapsed Acute Promyelocytic Leukemia
Intervention: Drug: Bortezomib
15 Completed JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab
Condition: Relapsing Multiple Sclerosis
Intervention: Drug: natalizumab
16 Completed Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia
Condition: Leukemia
Interventions: Genetic: protein expression analysis;   Genetic: western blotting;   Other: flow cytometry;   Other: laboratory biomarker analysis
17 Recruiting Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
Conditions: Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA;   Childhood Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA;   Untreated Adult Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Arsenic Trioxide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Idarubicin;   Other: Laboratory Biomarker Analysis;   Drug: Mitoxantrone Hydrochloride;   Other: Questionnaire Administration;   Drug: Tretinoin
18 Unknown  Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Intervention: Drug: NRX 195183 Soft Gelatin Capsule
19 Unknown  Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Intervention: Drug: Single agent arsenic trioxide
20 Completed Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia
Condition: Leukemia
Intervention: Drug: arsenic trioxide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years